The fact that cannabis has a strong medical and therapeutic potential is not new. Indeed, the question we should ask is not about if medical cannabis works: the key question is how to get the maximum therapeutic benefit from cannabis and what combination of cannabinoids is the most efficient.
I am talking about Sweet Pure Auto CBD® (SWS75), a 6th generation autoflowering strain included in the Sweet Seeds® therapeutic line due to its high CBD content and which has been shown a very good acceptance after its release in the market. In addition to its high cannabidiol (CBD) content, another highly valued feature is that it contains almost no THC (less than 1%), so it has no psychoactive effects.
I am talking about Sweet Pure Auto CBD® (SWS75), a 6th generation autoflowering strain included in the Sweet Seeds® therapeutic line due to its high CBD content and which has been shown a very good acceptance after its release in the market. In addition to its high cannabidiol (CBD) content, another highly valued feature is that it contains almost no THC (less than 1%), so it has no psychoactive effects.
Back in 1990, scientists made a remarkable discovery that both changed the way we view the human body and cannabis: the endocannabinoid system.
Background: In Italy medical cannabis is a prescription drug since 1998. Even though it could not be considered a therapy as such, it is indicated as a symptomatic treatment also in cancer patients, to cure iatrogenic nausea/vomiting and chronic pain.
There are conflicting interpretations of the evidence regarding the efficacy, tolerability, and safety of cannabinoids in pain management and palliative medicine.
This review illustrates some brief considerations of the medical use of cannabis recently issued in Italy. History and uses of cannabis throughout centuries and different countries are illustrated together with a description of botany and active phytocannabinoids.
The policies and practices related to medical cannabis are currently in flux. These changes have been associated with many controversies, and there is a lack of consensus within the medical community regarding medical cannabis practices.
As the legalization of medical cannabis continues across the USA, oncology care providers will be increasingly asked to provide recommendations regarding its use in the cancer setting. In this article, we review recent literature that analyzes cannabis use specifically in patients with cancer and provide an accessible guide for clinicians, researchers, and patients.
Cannabis has the potential to modulate some of the most common and debilitating symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and pain. However, the dearth of scientific evidence for the effectiveness of cannabis in treating these symptoms in patients with cancer poses a challenge to clinicians in discussing this option with their patients.